Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.

Eero RissanenKelsey CarterSteven CiceroJohn FickeMarie KijewskiMi-Ae ParkJoseph KijewskiEmily SternTanuja ChitnisDavid SilbersweigHoward L WeinerChun K KimJennifer LyonsJoshua P KleinShamik BhattacharyyaTarun Singhal

Published in: Neurology(R) neuroimmunology & neuroinflammation (2022)

This study provides Class II evidence that semiquantitative measures of putaminal metabolism on PET can differentiate patients with LGI1-AE from patients without LGI1-AE, patients with AD, or NCs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
multiple sclerosis
peritoneal dialysis
patient reported outcomes
positron emission tomography
pet ct
pet imaging